NCT05624398招募中不适用
Visual Outcomes and Patient Satisfaction in Subjects With Stable Open-angle Glaucoma Undergoing Concurrent Minimally Invasive Glaucoma Surgery and IOL Implantation With an Extended-depth-of-focus IOL
Vold Vision P.L.L.C2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2022年12月7日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 25
- 试验地点
- 2
- 主要终点
- Mean Photopic Monocular Best Corrected Distance Visual Acuity (DCVA) (4 meters) logMAR
研究概览
简要总结
This study is designed to determine how well patients with glaucoma can see following cataract surgery with a special type of lens called an extended-depth-of-focus (EDOF) lens. This lens is intended to reduced the patients need for glasses following cataract surgery. Patients will also undergo a minimally invasive type of glaucoma surgery using a special type of stent to reduce eye pressure, with the goal of better glaucoma control and the reduction in the need for medications to control eye pressure.
详细描述
To evaluate the range of vision and patient reported outcomes in subjects implanted with Clareon Vivity IOL undergoing concurrent MIGS with the Hydrus Microstent
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 45 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female subjects 45 years of age or older
- •A visually significant age-related cataract in both eyes
- •Diagnosis of mild OAG
- •VF characteristics consistent with glaucoma with mean deviation not worse than -6.00 dB and without fixation threatening scotoma AND/OR with nerve abnormalities consistent with glaucoma (rim notching, rim thinning, disc hemorrhage, nerve fiber layer loss)
- •Medicated IOP ≤25 mmHg on 1-3 hypotensive medications
- •Glaucoma must be judged as stable by investigator based on review of subject medical records
- •Stable VF at least 1 year prior to surgery
- •Stable nerve fiber layer at least 1 year prior to surgery
- •IOP stable on current medication regimen at least 3 months prior to surgery
- •Shaffer grade of ≥ III in all angle quadrants
- •Potential of best corrected visual acuity at distance in the investigator's judgement of at least 0.1 logMAR (20/25) postoperatively
- •Able and willing to comply with follow up visits
- •Understands and signs the informed consent
- •Both eyes of the subject should undergo surgery within 21 days of each other to ensure adequate timing for final visit window of 90 days ± 21 days post operatively
排除标准
- •Previous incisional glaucoma surgery or cilio-ablative surgery
- •Prior laser trabeculoplasty within 90 days of surgery
- •Pseudoexfoliative, angle closure, uveitic, congenital, traumatic, angle recession, or neovascular glaucoma.
- •Moderate glaucoma with VF mean deviation between -6.00 dB and -12.00 dB
- •Severe and/or progressive glaucoma defined as
- •VF mean deviation worse than -12.00 dB
- •Consistent worsening of visual field on review of subject medical records
- •Consistent and progressive thinning of nerve fiber layer on review of subject medical records
- •Uncontrolled IOP on maximum glaucoma medications
- •Historically poor IOP control with medical therapy
- •Severe focal notching of the optic nerve rim
- •Expectation for future need of incisional glaucoma surgery
- •Ocular pathology or other medical condition which, in the investigator's judgment places the subject at increased risk of complications or significant vision loss during study period
- •Ocular pathology that in the investigator's judgment may impact visual acuity postoperatively, i.e., significant ocular surface disease, corneal scarring, blepharitis, epiretinal membrane, macular degeneration, history of significant ocular trauma with sequela, etc.
- •Pregnant or breastfeeding women
- •Prior refractive surgery e.g., LASIK, RK, PRK, etc.
- •Subjects with significant complications during surgical procedure e.g., broken capsule, Hydrus Microstent complication, will be exited from the trial
- •Subjects who experience visually significant complications related to the Hydrus Microstent during the study period will be exited from the trial
结局指标
主要结局
Mean Photopic Monocular Best Corrected Distance Visual Acuity (DCVA) (4 meters) logMAR
时间窗: 3 months
Visual acuity measurement
次要结局
- Mean Photopic Binocular Uncorrected Intermediate Visual Acuity (UCIVA) (66 cm) logMAR(3 months)
- Mean Refractive Spherical Equivalent(3 months)
- Mean Photopic Monocular Uncorrected Distance Visual Acuity (UCDVA) (4 meters) logMAR(3 months)
- Mean Photopic Monocular Uncorrected Intermediate Visual Acuity (UCIVA) (66 cm) logMAR(3 months)
- Mean Photopic Binocular Best Distance Corrected Intermediate Visual Acuity (DCIVA) (66 cm) logMAR(3 months)
- Mean Photopic Binocular Uncorrected Distance Visual Acuity (UCDVA) (4 meters) logMAR(3 months)
- Mean Photopic Binocular Best Corrected Distance Visual Acuity (DCVA) (4 meters) logMAR(3 months)
- Mean Absolute Prediction Error(3 months)
- Mean Photopic Monocular Best Distance Corrected Intermediate Visual Acuity (DCIVA) (66 cm) logMAR(3 months)
- Mean post-op refractive astigmatism and the distribution of post-op refractive astigmatism at ≤0.25D, ≤0.50D, ≤0.75D, and ≤1.00D(3 months)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Comparision of Visual Outcomes and Patient Satisfaction Between Two Diffractive Trifocal Intraocular LensesCataract SenileNCT04655274Akdeniz University30
已完成
不适用
Patient Satisfaction With Contoura Vision Topography-Guided LASIKMyopiaAstigmatismNCT04903301Rush Eye Associates50
已完成
不适用
Vivity IOL: Emmetropia Compared to Monovision.PresbyopiaNCT05464732Carolina Eyecare Physicians, LLC33
终止
不适用
Visual Outcomes and Patient Satisfaction After Bilateral Implantation of Non-diffractive EDOF IOL Made of a New Hydrophobic Acrylic MaterialCataractNCT05488769Thomas Nagy6
Unknown
不适用
Patients' Satisfaction After LASIKRefractive ErrorsNCT04109040Assiut University50